Marijuana Abuse

"Marijuana Abuse" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Use of marijuana associated with abnormal psychological, social, and or occupational functioning.

Descriptor ID	D002189
MeSH Number(s)	C25.775.635 F03.900.635
Concept/Terms	Marijuana Abuse Marijuana Abuse Abuse, Marijuana Marihuana Abuse Abuse, Marihuana Hashish Abuse Hashish Abuse Abuse, Hashish Cannabis-Related Disorder Cannabis-Related Disorder Cannabis Related Disorder Disorder, Cannabis-Related Cannabis Abuse Cannabis Abuse Abuse, Cannabis Cannabis Dependence Cannabis Dependence Dependence, Cannabis Marijuana Dependence Dependence, Marijuana

Below are MeSH descriptors whose meaning is more general than "Marijuana Abuse".

Diseases [C]
Chemically-Induced Disorders [C25]
Substance-Related Disorders [C25.775]
Marijuana Abuse [C25.775.635]
Psychiatry and Psychology [F]
Mental Disorders [F03]
Substance-Related Disorders [F03.900]
Marijuana Abuse [F03.900.635]

Below are MeSH descriptors whose meaning is related to "Marijuana Abuse".

Below are MeSH descriptors whose meaning is more specific than "Marijuana Abuse".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Marijuana Abuse" by people in this website by year, and whether "Marijuana Abuse" was a major or minor topic of these publications.

Bar chart showing 99 publications over 23 distinct years, with a maximum of 10 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	1	1
1999	1	1	2
2000	1	0	1
2002	1	0	1
2003	2	0	2
2004	1	0	1
2006	4	1	5
2007	1	2	3
2008	5	3	8
2009	4	1	5
2010	4	0	4
2011	3	0	3
2012	6	4	10
2013	3	0	3
2014	4	0	4
2015	9	0	9
2016	6	0	6
2017	8	1	9
2018	9	0	9
2019	1	2	3
2020	5	0	5
2021	3	1	4
2022	1	0	1

Below are the most recent publications written about "Marijuana Abuse" by people in Profiles.

Borodovsky JT, Sofis MJ, Sherman BJ, Gray KM, Budney AJ. Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints. Psychol Addict Behav. 2022 Aug; 36(5):515-525.

View in: PubMed
McRae-Clark AL, Gray KM, Baker NL, Sherman BJ, Squeglia L, Sahlem GL, Wagner A, Tomko R. Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial. Drug Alcohol Depend. 2021 12 01; 229(Pt B):109111.

View in: PubMed
Prisciandaro JJ, Mellick W, Squeglia LM, Hix S, Arnold L, Tolliver BK. Results from a randomized, double-blind, placebo-controlled, crossover, multimodal-MRI pilot study of gabapentin for co-occurring bipolar and cannabis use disorders. Addict Biol. 2022 01; 27(1):e13085.

View in: PubMed
Sherman BJ, Sofis MJ, Borodovsky JT, Gray KM, McRae-Clark AL, Budney AJ. Evaluating cannabis use risk reduction as an alternative clinical outcome for cannabis use disorder. Psychol Addict Behav. 2022 Aug; 36(5):505-514.

View in: PubMed
Aloi J, Crum KI, Blair KS, Zhang R, Bashford-Largo J, Bajaj S, Schwartz A, Carollo E, Hwang S, Leiker E, Filbey FM, Averbeck BB, Dobbertin M, Blair RJR. Individual associations of adolescent alcohol use disorder versus cannabis use disorder symptoms in neural prediction error signaling and the response to novelty. Dev Cogn Neurosci. 2021 04; 48:100944.

View in: PubMed
Sherman BJ, Baker NL, Schmarder KM, McRae-Clark AL, Gray KM. Latency to cannabis dependence mediates the relationship between age at cannabis use initiation and cannabis use outcomes during treatment in men but not women. Drug Alcohol Depend. 2021 01 01; 218:108383.

View in: PubMed
Stephens RS, Walker R, DeMarce J, Lozano BE, Rowland J, Walker D, Roffman RA. Treating cannabis use disorder: Exploring a treatment as needed model with 34-month follow-up. J Subst Abuse Treat. 2020 10; 117:108088.

View in: PubMed
Loflin MJE, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, D'Souza DC, Dworkin RH, Gray KM, Hasin DS, Lee DC, Le Foll B, Levin FR, Lile JA, Mason BJ, McRae-Clark AL, Montoya I, Peters EN, Ramey T, Turk DC, Vandrey R, Weiss RD, Strain EC. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug Alcohol Depend. 2020 07 01; 212:107993.

View in: PubMed
Benitez A, Lauzon S, Nietert PJ, McRae-Clark A, Sherman BJ. Self-reported cognition and marijuana use in older adults: Results from the national epidemiologic survey on alcohol and related conditions-III. Addict Behav. 2020 09; 108:106437.

View in: PubMed
Connors N, Kosnett MJ, Kulig K, Nelson LS, Stolbach AI. ACMT Position Statement: Interpretation of Urine for Tetrahydrocannabinol Metabolites. J Med Toxicol. 2020 04; 16(2):240-242.

View in: PubMed

People

Explore

Similar Concepts

Top Journals